David Hulcoop is the Executive Director of Open Targets, a public-private consortium focused on identifying and prioritizing therapeutic targets for new medicines. He leverages his background in drug discovery and a PhD from the University of Cambridge to bridge the gap between academic and industrial science, enhancing translational impact.
He is passionate about solving complex, multi-dimensional problems in drug discovery, viewing target selection as the most critical challenge in the field. David is actively involved in supporting research for neurodegenerative diseases, including contributing to frameworks that aid in understanding Motor Neurone Disease (MND).
He has experience bridging organizational cultures to address critical challenges in drug discovery and has worked with the My Name5 Doddie Foundation.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.